Federal vaccine policy has undergone a sweeping transformation, pivoting away from decades of expert-driven immunization frameworks toward a model that emphasizes fewer recommended routine childhood vaccinations, heightened individual decision-making, and increased skepticism regarding the safety and efficacy of certain vaccines. Spearheaded by the Department of Health and Human Services under the Trump administration, these sweeping policy modifications have coincided with a notable decline in childhood vaccination coverage, a rise in non-medical exemptions for school entry, and the most severe resurgence of measles in decades.
Public trust in federal health institutions, particularly the Centers for Disease Control and Prevention, remains near historic lows, while states increasingly chart their own courses. Dozens of jurisdictions have broken away from federal immunization guidelines to protect public health within their borders, creating a fragmented national landscape where vaccine requirements, recommendations, and insurance coverage can vary significantly depending on state lines.
Overview
Since January 2025, the Trump administration has executed fundamental alterations across the federal apparatus governing public health immunization strategies. These shifts touch every level of policy, including which inoculations are officially recommended, the composition of the advisory bodies that formulate these guidelines, and the core public messaging emanating from Washington, D.C.
The developments represent a profound departure from a long-standing, expert-driven federal vaccine framework that historically enjoyed broad bipartisan support and prioritized comprehensive routine childhood immunizations. Instead, the current administration has implemented narrower federal recommendations, decreased the number of childhood vaccinations deemed routine, encouraged greater state-level policy variation, and placed heightened reliance on individual clinical decision-making.
These changes are unfolding against an already precarious public health backdrop. Well before the policy shift, childhood vaccination rates were trending downward across multiple states, and preventable infectious diseases such as measles had begun staging aggressive comebacks.
Key Developments
The overhaul of federal health policy has been driven largely by Health and Human Services Secretary Robert F. Kennedy Jr., a prominent and long-standing critic of federal vaccine programs who has repeatedly questioned the safety and effectiveness of standard immunizations. Kennedy is also a leading figure in the "Make America Healthy Again" (MAHA) movement, a political and social coalition that has elevated issues such as corporate influence within federal health agencies, broader chemical exposure in the food supply, and rigorous re-evaluations of vaccine safety.
The restructuring began in earnest in June 2025, when Secretary Kennedy dismissed and replaced every member of the Advisory Committee on Immunization Practices (ACIP), the independent expert panel legally charged with providing evidence-based immunization recommendations to the CDC.
Throughout 2025, a series of cascading policy shifts followed. The CDC initially revoked its prior recommendation advising routine COVID-19 vaccinations for healthy children and pregnant women. Later, acting in alignment with guidance from the newly reconstituted ACIP, the agency revised its broader immunization schedule to recommend "shared clinical decision-making" for COVID-19 vaccines, replacing definitive routine guidance. By December, ACIP members voted to dismantle a 34-year-old federal recommendation that all healthy newborns receive the hepatitis B vaccine within 24 hours of birth.
That same month, federal health officials altered administrative reporting requirements within Medicaid and the Children’s Health Insurance Program, making state-level vaccination reporting voluntary rather than mandatory. Public health advocates warned that this change could obscure critical data, making it substantially harder for researchers and officials to monitor, track, and understand pediatric vaccination trends nationwide.
The most sweeping structural overhaul arrived in January 2026, when HHS formally adopted a radically revised childhood vaccination schedule. The updated schedule slashed the number of targeted diseases from 17 down to 11 and reduced the number of routine vaccines from 13 to 7. This sharp contraction positioned the United States as an outlier among peer nations regarding public health recommendations.
Under the revised framework, six major vaccines are no longer recommended for routine administration to all children in the United States: rotavirus, COVID-19, influenza, hepatitis A, hepatitis B, and meningococcal vaccines. While some of these inoculations remain recommended for narrower, specific subsets of children, all six were shifted away from the routine category into the classification of shared clinical decision-making. However, the implementation of these revised HHS recommendations has faced immediate legal hurdles, with a federal judge temporarily blocking the changes.
The executive branch continued to press its agenda in August, when the White House issued an executive order reiterating the restructuring of the childhood immunization schedule. The order also directed the HHS Secretary to make specific childhood vaccines—such as the measles, mumps, and rubella (MMR) vaccine—available as single-antigen formulations rather than combination products, meaning they would be administered as three distinct shots instead of a single combined injection.
Throughout this period, President Trump and Secretary Kennedy have repeatedly voiced public safety concerns regarding vaccines, including advancing unsupported claims linking childhood immunizations to autism and attributing the rise of chronic illnesses in children to vaccine usage—assertions that lack scientific backing and contradict the consensus of major medical organizations.
Concurrently, state-level policies have shifted. Since 2025, at least nine states have enacted legislative or administrative changes making non-medical exemptions to mandatory school vaccination policies more permissive. These adjustments have often involved reducing required documentation or streamlining administrative hurdles for parents. Public health research consistently indicates that policies making non-medical exemptions easier to obtain correlate directly with higher exemption rates and subsequent declines in overall childhood immunization coverage.
Recent Issues and Looking Ahead
Faced with shifting federal guidelines, an increasing number of state governments have begun severing their institutional ties to federal immunization recommendations. By August 2026, health authorities in 30 states and the District of Columbia announced they would no longer follow CDC and ACIP recommendations for one or more childhood vaccines. Among them, 27 states completely delinked their school and public health requirements from CDC and ACIP guidelines across all childhood vaccines, choosing instead to rely on historical guidelines, independent state health recommendations, or the expert guidance of external organizations such as the American Academy of Pediatrics.
The federal modifications have also triggered significant legal and logistical concerns surrounding health insurance coverage. Historically, many private health insurance plans, state Medicaid programs, and the federally funded Vaccines for Children initiative have been legally mandated to cover ACIP-recommended immunizations without imposing cost-sharing on patients. Alterations to federal recommendations can theoretically alter which products insurers must provide at no out-of-pocket cost.
In practice, the effect has been mitigated because individual states maintain the authority to establish separate insurance coverage mandates, particularly for state-regulated health plans and mandatory school entry requirements. Consequently, actual vaccine recommendations and the scope of insurance coverage available to families can vary widely from state to state. For the time being, major health insurers have indicated they will maintain their current coverage parameters, and the ongoing federal court injunction keeps the HHS schedule changes frozen.
These policy battles are playing out against a baseline of falling vaccination coverage. Data from the 2025-2026 school year show that 92.4% of kindergarteners had received vaccinations against measles, mumps, rubella, and polio, while 92.0% were vaccinated against diphtheria, tetanus, and pertussis (DTaP). These figures represent a notable drop from the 95% coverage levels recorded across all three categories during the 2019-2020 pre-pandemic school year, falling below the thresholds maintained over the preceding decade. Concurrently, the national share of kindergarteners holding exemptions from one or more school vaccine requirements climbed to 4.2%, up sharply from 2.5% in 2019-2020.
Epidemiologists note that achieving a vaccination coverage rate of at least 95% is essential to maintain community-level immunity and prevent the widespread transmission of measles. By the 2025-2026 term, 39 states reported MMR coverage levels below the critical 95% threshold, with 18 states falling below 90%.
Although the United States officially achieved measles elimination status in 2000, the country has experienced a severe resurgence of the virus over the past two years. Federal data shows that nearly 3,887 confirmed cases of measles were reported nationwide by October 1, 2026—surpassing the total for the entirety of 2025, marking the highest annual case count since 1991, and actively threatening the nation’s official elimination status. While measles cases have emerged in the majority of states, South Carolina, Utah, Pennsylvania, Texas, and Virginia have experienced the largest and most concentrated outbreaks of 2026.
The Public’s Views
Polling conducted by KFF indicates that public confidence in the CDC remains severely depressed in the wake of the Trump administration’s restructuring of childhood vaccine schedules. Fewer than half of Americans, precisely 47%, report trusting the agency at least "a fair amount" to deliver reliable information regarding vaccines. This figure represents a decline of more than 10 percentage points since the beginning of the second Trump administration, continuing a downward trajectory in institutional trust that began during the COVID-19 pandemic. Trust levels remain deeply polarized along partisan lines, with the recent downward shift driven primarily by eroding confidence among Democrats.
When evaluating broader policy performance, public opinion remains divided. Approximately four in ten voters approve of the Trump administration’s handling of vaccine policy, standing at 38%, while six in ten, or 61%, express disapproval. In terms of political trust regarding health policy management, Democrats hold an advantage over Republicans, with 41% of voters expressing trust in Democrats compared to 25% for Republicans, while a quarter of voters place their trust in neither major party.
While portions of the administration’s policy agenda were designed to resonate with supporters of the Make America Healthy Again movement, polling among MAHA voters reveals complex priorities. When asked about the federal government’s top health care objective, four in ten MAHA-supporting voters point to lowering overall health care costs, whereas only one in ten select the re-evaluation of vaccine safety as their primary concern.
